RESEARCH & DEVELOPMENT We bring bright scientists to work together on challenging technologies
Our research program began in 1999 with the establishment of a partnership to bridge the funding and technology commercialization gap that exists between science and business. We expand the professional opportunities of academic-based biomedical scientists by providing financial support through Federal, State and private research funds, encouraging academic scientists to collaborate in the development of new, challenging technologies.
The company focuses on projects in the fields of inflammation, coagulation, and tissue regeneration with commercial and military applications. Its leading technology, ClotFoam, is an intracavitary hemostatic agent -ClotFoam- for use in non-compressible high volume hemorrhage. This platform technology has important applications in trauma, laparoscopic surgery and wound healing. Other products in development include a selectin blocker with anti-ischemic properties (Neutrolide), for application in transplantation and resuscitation fluids; and a glycolipid derivative (Glyco 23) for the treatment of sepsis.
If we look two years into the future we see over 60 percent of surgical procedures conducted with minimally invasive laparoscopic techniques, using non-compressible hemostatic agents such as ClotFoam; and a substantial improvement in life saving procedures following accidents and other traumatic events, including casualties in the battlefield.
Three years from now we expect to prevent or control the development of sepsis without antibiotics, and extend the life of organs stored for transplantation. Each of these technologies will save countless lives and play a leading role in a combined market of $ 3 billion .
Wound sealants
and tissue repair coats.
ClotFoam
Non-compressible Hemostatic technologyProduct Specification
Preclinical Studies
Neutrolide
Anti-ischemic Agents
Sepsis
Martin Bluth, MD, PhD
Director of Research
Wayne State University
Bill LaCourse, Ph.D., Chairman and Professor of Chemistry
Department of Chemistry and Biochemistry
University of Maryland Baltimore County
Aristotle Kalivretenos, PhD
Chemist
Leonid Medved, Ph.D.
Professor of Biochemistry and Molecular Biology
University of Maryland, School of Medicine
Center for Vascular and Inflammatory Diseases
Department of Biochemistry and Molecular Biology
Jorge Fishbarg, MD Professor of Physiology
Eye Instititute, School of Medicine, Columbia University, New York
Grant Bochicchio, MD PhD
Professor & Director
University of Maryland Baltimore Trauma Center
Maja Nowakowski, Ph.D.
Associate Professor, Dept. Pathology
SUNY Downstate, New York